Palatin 's actual results may differ materially from those discussed in the forward-looking statements for various reasons , including , but not limited to Palatin 's ability to fund development of its technology , ability to establish and successfully complete clinical trials and pre-clinical studies and the results of those trials and studies , dependence on its partners for certain development activities , need for regulatory approvals and commercial acceptance of its products , ability to protect its intellectual property , and other factors discussed in the Palatin 's periodic filings with the Securities and Exchange Commission .